The Valley Desk

Clinical trial reportThe Lancet. NeurologyPublished

Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, Thomas Jefferson University, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
The Lancet. Neurology
Published
Subject terms
Humans; Friedreich Ataxia; Niacinamide; Pyridinium Compounds; Treatment Outcome; Exercise Therapy; Dietary Supplements; Adolescent; Adult; Child; United States; Female
PubMed ID
42009009
PubMed Central ID
PMC13162205
Added to directory
Source checked

Report a correction or request removal